Groups recommend HER2 testing to all women with invasive breast cancer

10/7/2013 | HealthDay News

The American Society of Clinical Oncology and the College of American Pathologists released guidelines urging all women with invasive breast cancer to be screened for the human epidermal growth factor receptor 2 gene and protein. Women with HER2-positive cancer should get HER2-targeted therapies, and those treatments should be not used for HER2-negative cancers, according to the guidelines published in the Journal of Clinical Oncology and the Archives of Pathology & Laboratory Medicine.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC